drugset / Trial / NCT06057168
Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas
RandomizedParallel-groupSingle-blindDiagnostic
Summary
This trial aimed to study the performance of Elucirem (gadopiclenol) in Dynamic Susceptibility Contrast Magnetic Resonance Imaging (DSC-MRI) perfusion of brain gliomas.
Timeline
- Start
- 2023-09-07
- Primary completion
- 2024-11-28
- Completion
- 2024-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadopiclenol | Diagnostic / imaging agent | — | Intravenous |
| Comparator | Gadoterate meglumine | Diagnostic / imaging agent | — | Intravenous |